Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1637 USD | +2.12% | -1.39% | -24.28% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 41.06M |
---|---|---|---|---|---|
Net income 2024 * | -25M | Net income 2025 * | -34M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.64
x | P/E ratio 2025 * |
-1.49
x | Employees | 32 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.47% |
Latest transcript on Matinas BioPharma Holdings, Inc.
1 day | +2.12% | ||
1 week | -1.39% | ||
1 month | -10.35% | ||
3 months | -43.80% | ||
6 months | -22.05% | ||
Current year | -24.28% |
Managers | Title | Age | Since |
---|---|---|---|
Jerome Jabbour
FOU | Founder | 50 | 13-04-30 |
Keith Kucinski
DFI | Director of Finance/CFO | 55 | 19-01-02 |
Hui Liu
CTO | Chief Tech/Sci/R&D Officer | 56 | 20-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
FOU | Founder | 91 | 13-04-30 |
Natasha Giordano
BRD | Director/Board Member | 62 | 20-09-13 |
Eric Ende
CHM | Chairman | 55 | 17-04-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.1637 | +2.12% | 728,454 |
24-05-30 | 0.1603 | -1.84% | 932,470 |
24-05-29 | 0.1633 | -2.45% | 785,876 |
24-05-28 | 0.1674 | +0.84% | 644,136 |
24-05-24 | 0.166 | +0.61% | 544,334 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.28% | 41.06M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- MTNB Stock